Upload

Loading...

Adding Tomorrows - CF Foundation 03:40

8,038

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 10, 2012

The FDA recently approved Kalydeco, the first drug to address the underlying cause of cystic fibrosis for a small segment of the CF population. Meet two children who are still in need of a lifesaving treatment for CF.

Loading...

Advertisement
When autoplay is enabled, a suggested video will automatically play next.

Up Next


Sign in to add this to Watch Later

Add to